ALYSSA MILES: Open Payments
NPI 1851586986 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$583 in 22 payments from 8 companies in 2025. Trend: 2023 $86 · 2024 $213 · 2025 $583
Food & beverage: $583
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $152 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $141 |
| Otsuka America Pharmaceutical, Inc. | 3 | $78 |
| Amgen Inc. | 4 | $70 |
| Ardelyx, Inc. | 2 | $51 |
| Vantive US Healthcare LLC | 1 | $50 |
| ANI Pharmaceuticals, Inc. | 1 | $24 |
| NxStage Medical, Inc. | 1 | $16 |
Products named: LOKELMA, Kerendia, JYNARQUE, KRYSTEXXA, IBSRELA, Renal - PD, PURIFIED CORTROPHIN GEL, NXSTAGE SYSTEM ONE.
Industry payments across NY — which companies pay providers there.
